Market Value321,489,380
Total Holdings75
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AMLX / Amylyx Pharmaceuticals, Inc.
PRDS / Pardes Biosciences Inc
LYRA / Lyra Therapeutics, Inc.
ISEE / IVERIC bio Inc
MDNA / Medicenna Therapeutics Corp
SURF / Surface Oncology Inc
RGLS / Regulus Therapeutics Inc.
NVRO / Nevro Corp.
TSVT / 2seventy bio, Inc.
SPRB / Spruce Biosciences, Inc.
IPSC / Century Therapeutics, Inc.
IMVT / Immunovant, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
RCUS / Arcus Biosciences, Inc.
ACET / Adicet Bio, Inc.
TNDM / Tandem Diabetes Care, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
BHVN / Biohaven Ltd.
XENE / Xenon Pharmaceuticals Inc.
MGNX / MacroGenics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
KURA / Kura Oncology, Inc.
GOSS / Gossamer Bio, Inc.
ATRC / AtriCure, Inc.
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
KALV / KalVista Pharmaceuticals, Inc.
VIGL / Vigil Neuroscience, Inc.
MASI / Masimo Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
CGEN / Compugen Ltd.
MRUS / Merus N.V.
LRMR / Larimar Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
PRQR / ProQR Therapeutics N.V.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
DICE / DICE Therapeutics Inc
AXGN / Axogen, Inc.
VKTX / Viking Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
SPRO / Spero Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
NXTC / NextCure, Inc.
MRSN / Mersana Therapeutics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
ACRV / Acrivon Therapeutics, Inc.
PRCT / PROCEPT BioRobotics Corporation
LCTX / Lineage Cell Therapeutics, Inc.
ELEV / Elevation Oncology, Inc.
EWTX / Edgewise Therapeutics, Inc.
STRO / Sutro Biopharma, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
NRIX / Nurix Therapeutics, Inc.
STIM / Neuronetics, Inc.
KRTX / Karuna Therapeutics, Inc.
CGEM / Cullinan Therapeutics, Inc.
SLRN / Acelyrin, Inc.
NBIX / Neurocrine Biosciences, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
ARAY / Accuray Incorporated
STXS / Stereotaxis, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
RVMD / Revolution Medicines, Inc.
KROS / Keros Therapeutics, Inc.
DXCM / DexCom, Inc.
BPMC / Blueprint Medicines Corporation
THRD / Third Harmonic Bio, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
MORF / Morphic Holding, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
KNTE / Kinnate Biopharma Inc.
INGN / Inogen, Inc.
ATXS / Astria Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
MDWD / MediWound Ltd.
CYTK / Cytokinetics, Incorporated
CMPX / Compass Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
KPTI / Karyopharm Therapeutics Inc.
ALEC / Alector, Inc.